ROTH Capital Partners announced that Adam Stormoen joined the firm as a director in its Healthcare Investment Banking group, focusing on healthcare services and medical devices.

“We are pleased to announce the addition of Adam to our healthcare team, said John Chambers, vice chairman and head of Healthcare Investment Banking at ROTH. “We believe his client universe and breadth of experience in providing financing and strategic advice to emerging growth companies will be an excellent fit with our team and strategy.”

Prior to joining ROTH, Stormoen spent five years at Dougherty & Company, where he helped to build the corporate finance practice by focusing on small-cap and mid-cap healthcare and consumer companies.

“I’m excited to be joining such a robust practice as ROTH’s healthcare group and I’m looking forward to leveraging my relationships and ROTH’s exceptional track record to help expand the business,” said Stormoen.